Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

医学 脂肪性肝炎 氧化应激 药理学 脂肪肝 肝硬化 肝细胞癌 血管生成 肝再生 肝细胞 癌症研究 肝癌 癌症 肝损伤 内科学 再生(生物学) 化学 生物 体外 生物化学 疾病 细胞生物学
作者
János Fehér,Gabriella Lengyel
出处
期刊:Current Pharmaceutical Biotechnology [Bentham Science Publishers]
卷期号:13 (1): 210-217 被引量:213
标识
DOI:10.2174/138920112798868818
摘要

In chronic liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty liver diseases, drug- and chemical-induced hepatic toxicity), the antioxidant medicines such as silymarin can have beneficial effect. Liver cirrhosis, non-alcoholic fatty liver and steatohepatitis are risk factors for hepatocellular carcinoma (HCC). Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading the hepatic cell injury in these patients. The silymarin exerts membrane-stabilizing and antioxidant activity, it promotes hepatocyte regeneration; furthermore it reduces the inflammatory reaction, and inhibits the fibrogenesis in the liver. These results have been established by experimental and clinical trials. According to open studies the long-term administration of silymarin significantly increased survival time of patients with alcohol induced liver cirrhosis. Based on the results of studies using methods of molecular biology, silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Furthermore, it exerts an anti-atherosclerotic effect, and suppresses tumor necrosis factor-alpha-induced protein production and mRNA expression due to adhesion molecules. The chemopreventive effect of silymarin on HCC has been established in several studies using in vitro and in vivo methods; it can exert a beneficial effect on the balance of cell survival and apoptosis by interfering cytokines. In addition to this, anti-inflammatory activity and inhibitory effect of silymarin on the development of metastases have also been detected. In some neoplastic diseases silymarin can be administered as adjuvant therapy as well. Keywords: Cancer prevention, chronic liver diseases, hepatitis B virus, hepatitis C virus, hepatocellular carcinoma, silymarin, steatohepatitis, oxidative stress, Liver cirrhosis, membrane-stabilizing, insulin resistance, metastases, adjuvant therapy, hepatobiliary diseases
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无敌小帅关注了科研通微信公众号
刚刚
1秒前
guohuameike完成签到,获得积分10
2秒前
科研小白鼠完成签到,获得积分20
2秒前
沉静的蜗牛完成签到,获得积分10
2秒前
小聖完成签到 ,获得积分10
3秒前
嘻嘻嘻发布了新的文献求助10
3秒前
luxx完成签到,获得积分10
4秒前
山大王yoyo发布了新的文献求助10
5秒前
pluto应助科研通管家采纳,获得10
5秒前
brd应助科研通管家采纳,获得10
5秒前
汉堡包应助科研通管家采纳,获得10
5秒前
pluto应助科研通管家采纳,获得10
5秒前
领导范儿应助科研通管家采纳,获得10
5秒前
传奇3应助科研通管家采纳,获得10
5秒前
wanci应助科研通管家采纳,获得10
6秒前
bkagyin应助科研通管家采纳,获得30
6秒前
我是老大应助科研通管家采纳,获得10
6秒前
yar应助科研通管家采纳,获得10
6秒前
丘比特应助科研通管家采纳,获得10
6秒前
6秒前
酷波er应助科研通管家采纳,获得10
6秒前
坚定萤完成签到,获得积分10
6秒前
脑洞疼应助科研通管家采纳,获得10
6秒前
赘婿应助科研通管家采纳,获得10
6秒前
wuyuzegang应助科研通管家采纳,获得20
6秒前
科研通AI5应助科研通管家采纳,获得10
7秒前
7秒前
NexusExplorer应助科研通管家采纳,获得10
7秒前
Owen应助科研通管家采纳,获得10
7秒前
天天快乐应助科研通管家采纳,获得10
7秒前
7秒前
7秒前
传奇3应助科研通管家采纳,获得10
7秒前
7秒前
lemonli完成签到,获得积分20
8秒前
8秒前
20231125完成签到,获得积分10
8秒前
8秒前
CipherSage应助DDKK采纳,获得10
8秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Handbook of Marine Craft Hydrodynamics and Motion Control, 2nd Edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3986953
求助须知:如何正确求助?哪些是违规求助? 3529326
关于积分的说明 11244328
捐赠科研通 3267695
什么是DOI,文献DOI怎么找? 1803880
邀请新用户注册赠送积分活动 881223
科研通“疑难数据库(出版商)”最低求助积分说明 808620